NIH Funding Announcements

Syndicate content
Weekly Funding Opportunities and Policy Notices from the National Institutes of Health.
Updated: 9 hours 25 min ago

NHLBI Announces Plans to Fund a Jackson Heart Study Exam 4

Wed, 10/18/2017 - 02:52
Notice NOT-HL-17-542 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Tue, 10/17/2017 - 12:42
Funding Opportunity PAR-18-324 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to fund highly innovative and promising research that tests multi-level physical activity intervention programs acting on at least two levels of the socio-ecological model and designed to increase health-enhancing physical activity: 1) in persons or groups that can benefit from such activity; and 2) that could be made scalable and sustainable for broad use across the nation. This FOA provides support for up to 5 years for research planning, intervention delivery, and follow-up activities.
Categories: NIH-Funding

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Field Center

Tue, 10/17/2017 - 09:51
Notice NOT-HL-17-555 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Coordinating Center

Tue, 10/17/2017 - 09:42
Notice NOT-HL-17-552 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Community Engagement Center

Tue, 10/17/2017 - 09:42
Notice NOT-HL-17-553 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of Upcoming Webinar for the Jackson Heart Study Renewal - Training and Education Center

Tue, 10/17/2017 - 09:42
Notice NOT-HL-17-554 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of Change to Award Budget Section for PAR-17-485 "NIMH Research Education Mentoring Program for HIV/AIDS Researchers (R25)"

Tue, 10/17/2017 - 02:38
Notice NOT-MH-18-002 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

RFP Announcement: Jackson Heart Study Renewal - Field Center

Mon, 10/16/2017 - 09:52
Notice NOT-HL-17-556 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Notice of Correction to PAR-17-496, Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Fri, 10/13/2017 - 13:03
Notice NOT-CA-18-001 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Fundamental Science Research on Mind and Body Approaches (R21 - Clinical Trial Optional)

Fri, 10/13/2017 - 12:58
Funding Opportunity PA-18-322 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) encourages exploratory /developmental research grant applications (R21) to investigate the fundamental science of mind and body approaches, including mind/brain-focused practices (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), meditative exercise (e.g., yoga, tai chi, qi gong), art and music therapies, or integrative approaches combining several components. Studies of pharmacologic approaches exclusively are not included in the scope of this FOA.
Categories: NIH-Funding

Fundamental Science Research on Mind and Body Approaches (R01 - Clinical Trial Optional)

Fri, 10/13/2017 - 12:58
Funding Opportunity PA-18-323 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research grant applications (R01) to investigate the fundamental science of mind and body approaches, including mind/brain-focused practices (e.g., meditation, hypnosis), body-based approaches (e.g., acupuncture, massage, spinal manipulation/mobilization), meditative exercise (e.g., yoga, tai chi, qi gong), art and music therapies, or integrative approaches combining several components. Studies of pharmacologic approaches exclusively are not included in the scope of this FOA.
Categories: NIH-Funding

HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)

Fri, 10/13/2017 - 12:15
Funding Opportunity PAR-18-319 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support multi-component, multi-disciplinary projects that address scientific questions relevant to AIDS prophylactic vaccine discovery research. Extensive modeling of vaccine concepts in non-human primates may be included.
Categories: NIH-Funding

Minority-Patient Derived Xenograft (PDX) Development and Trial Center (PDTC) Network (U54)

Fri, 10/13/2017 - 02:38
Funding Opportunity RFA-CA-17-032 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) solicits applications for Minority PDX (minority patient-derived xenografts) Development and Trial Centers (M-PDTCs). The M-PDTCs will join the PDTC Research Network (PDXNet) and be focused upon development and pre-clinical testing of models derived from racial/ethnic minority populations. The PDXNet is a National Cancer Institute (NCI) program established to coordinate collaborative, large-scale model development and pre-clinical testing of targeted therapeutic agents to advance the vision of cancer precision medicine.
Categories: NIH-Funding

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20)

Fri, 10/13/2017 - 02:38
Funding Opportunity RFA-CA-17-033 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) invites applications for development of translational research programs that are focused upon investigating cancer health disparities. The P20 grants will support feasibility and planning activities to build cancer health disparities research programs. It is the expectation that the research programs developed by the P20 awards should be competitive with other applications for a full Specialized Programs of Research Excellence (SPORE), addressing cancer health disparities as a cross-cutting research theme.
Categories: NIH-Funding

BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)

Thu, 10/12/2017 - 12:39
Funding Opportunity RFA-EB-17-005 from the NIH Guide for Grants and Contracts. This FOA solicits new theories, computational models, and statistical tools to derive understanding of brain function from complex neuroscience data. Proposed tools could include the creation of new theories, ideas, and conceptual frameworks to organize/unify data and infer general principles of brain function; new computational models to develop testable hypotheses and design/drive experiments; and new mathematical and statistical methods to support or refute a stated hypothesis about brain function, and/or assist in detecting dynamical features and patterns in complex brain data. It is expected that the tools developed under this FOA will be made widely available to the neuroscience research community for their use and modification. Investigative studies should be limited to validity testing of the tools being developed.
Categories: NIH-Funding

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp)

Thu, 10/12/2017 - 12:21
Funding Opportunity PA-18-314 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) seeks to develop and nurture a national innovation ecosystem that builds upon biomedical research to develop technologies, products, and services that benefit society. Toward meeting this objective, the I-Corps program is being offered. The I-Corps at NIH program is focused on educating researchers and technologists on how to translate technologies from the lab into the marketplace. Under this FOA, participating NIH and CDC Institutes and Centers will continue providing administrative supplement awards to currently-funded SBIR and STTR Phase I grantees.
Categories: NIH-Funding

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)

Thu, 10/12/2017 - 11:38
Funding Opportunity PAR-18-313 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) invites applications for P50 Research Center Grants for Specialized Programs of Research Excellence (SPOREs). The program will fund P50 SPORE grants to support state-of-the-art investigator-initiated translational research that will contribute to improved prevention, early detection, diagnosis, and treatment of an organ-specific cancer or a related group of cancers. For the purpose of this FOA, cancers derived from the same organ system (i.e., a group of organs that perform a common function) are considered related. Examples of such organ systems include gastrointestinal, endocrine and other biological systems. Other programmatically appropriate groups of cancers may include those centered around a common biological mechanism critical for promoting tumorigenesis and/or cancer progression in organ sites that belong to different organ systems. For example, a SPORE may focus on cancers caused by the same infectious agent or cancers sustained and promoted by dysregulation of a common signaling pathway. In addition, a SPORE may focus on cross-cutting themes such as pediatric cancers or cancer health disparities. The research supported through this program must be translational and must stem from research on human biology using cellular, molecular, structural, biochemical, and/or genetic experimental approaches. SPORE projects must have the goal of reaching a translational human endpoint within the project period of the grant.
Categories: NIH-Funding

RFP Announcement: Jackson Heart Study Renewal - Coordinating Center, Field Center, Community Engagement Center, and Training and Education Center

Thu, 10/12/2017 - 03:40
Notice NOT-HL-17-544 from the NIH Guide for Grants and Contracts
Categories: NIH-Funding

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)

Thu, 10/12/2017 - 03:33
Funding Opportunity PAR-18-317 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support the validation of molecular/cellular/imaging markers and assays for cancer detection, diagnosis, prognosis, monitoring, and prediction of response or resistance to treatment, as well as markers for cancer prevention and control. This FOA also includes the validation of pharmacodynamic markers and markers of toxicity. Applicants should have assays that work on human samples and whose importance is well justified for development into clinical assays. As chemotherapies and/or radiation therapies are increasingly combined with immunotherapies to enhance durability of anti-cancer responses, multiple assays for measuring multiple markers, including immune markers, can be developed and validated simultaneously.
Categories: NIH-Funding